Literature DB >> 17177941

A case of argyria after colloidal silver ingestion.

Anne Lynn S Chang1, Vista Khosravi, Barbara Egbert.   

Abstract

BACKGROUND: Argyria is often considered an entity of the past, one which has largely disappeared with the cessation of silver usage in oral medications. However, with the practice of colloidal silver ingestion in current "alternative health" treatments, argyria should be considered in the differential diagnosis of blue-gray hyperpigmentation.
METHODS: A single case report with clinicopathological correlation.
RESULTS: Histological examination of skin biopsy specimen, which showed perieccrine brown-black granules, verified that colloidal silver rather than a prescribed medication was the source of the patient's dyspigmentation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17177941     DOI: 10.1111/j.1600-0560.2006.00557.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  11 in total

1.  Silver nanoparticles engineered by thermal co-reduction approach induces liver damage in Wistar rats: acute and sub-chronic toxicity analysis.

Authors:  Nandita Dasgupta; Shivendu Ranjan; Chidambaram Ramalingam; Mansi Gandhi
Journal:  3 Biotech       Date:  2019-03-06       Impact factor: 2.406

Review 2.  Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future.

Authors:  Rochelle R Arvizo; Sanjib Bhattacharyya; Rachel A Kudgus; Karuna Giri; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

3.  Toxicology and clinical potential of nanoparticles.

Authors:  Lara Yildirimer; Nguyen T K Thanh; Marilena Loizidou; Alexander M Seifalian
Journal:  Nano Today       Date:  2011-12       Impact factor: 20.722

4.  Acute and subchronic dermal toxicity of nanosilver in guinea pig.

Authors:  M Korani; S M Rezayat; K Gilani; S Arbabi Bidgoli; S Adeli
Journal:  Int J Nanomedicine       Date:  2011-04-27

5.  Generalized Argyria Successfully Treated with Q-switched Alexandrite Laser: A Case Report.

Authors:  Maiko Fukayama; Yoshihide Asano; Jun Omatsu; Haruka Kawashima; Akira Shirai; Shinichi Sato
Journal:  Acta Derm Venereol       Date:  2020-12-14       Impact factor: 3.875

6.  Side-by-side Comparison of a Picosecond 755-nm Alexandrite Laser and a Quality-switched 1064-nm Neodymium-doped Yttrium Aluminum Garnet Laser in the Treatment of Argyria.

Authors:  Emma Weiss; Kaitlyn L Streight; Christopher B Rizk; Ramsey Markus
Journal:  Cureus       Date:  2019-07-23

Review 7.  Clinical and Forensic Aspects of the Different Subtypes of Argyria.

Authors:  Luís Mota; Ricardo Jorge Dinis-Oliveira
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

8.  A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles.

Authors:  Gerald Bachler; Natalie von Goetz; Konrad Hungerbühler
Journal:  Int J Nanomedicine       Date:  2013-09-02

9.  Argyria after Silver Nitrate Intake: Case Report and Brief Review of Literature.

Authors:  Alma Ileana Molina-Hernandez; Jose Manuel Diaz-Gonzalez; Marcela Saeb-Lima; Judith Dominguez-Cherit
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

10.  An Effective Modality for Argyria Treatment: Q-Switched 1,064-nm Nd:YAG Laser.

Authors:  Se-Won Park; Jun-Hwan Kim; Hyun-Tae Shin; Kyung-Tae Lee; Jong-Hee Lee; Dong-Youn Lee; Joo-Heung Lee; Jun-Mo Yang
Journal:  Ann Dermatol       Date:  2013-11-30       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.